4-group clinical interventional study
Showing 1 - 25 of >10,000
ONS Nutridrink® 200 ml on Recovery of COVID-19 and Respiratory
Completed
- COVID-19
- Nutridrink ONS 200 ml
-
Ekaterinburg, Russian Federation
- +5 more
Oct 12, 2022
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution
Not yet recruiting
- Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
- Cannabidiol Oral Solution [Epidiolex]
-
Los Angeles, California
- +6 more
May 9, 2023
Cerebral Angiography Trial in Shanghai (Interventional Robotic System)
Recruiting
- Cerebral Angiography
- Interventional Robotic System
-
Shanghai, Shanghai City, ChinaChanghai Hospital
Mar 18, 2023
Epidemic Meningitis Trial (MCV4, MSPV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- MSPV4
- (no location specified)
Aug 21, 2023
Percutaneous Coronary Intervention, Coronary Heart Disease, Robotic Surgical Procedures Trial (ALLVAS® robotic-assisted PCI)
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- ALLVAS® robotic-assisted PCI
- (no location specified)
Dec 7, 2022
Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)
Not yet recruiting
- Rabies
- 5-dose group of test vaccine
- +3 more
-
Chengdu, Sichuan, China
- +3 more
Jul 23, 2023
Budapest Upgrade CRT Study (Version 009-4.1)
Active, not recruiting
- Cardiomyopathy
- CRT-D
-
Hannover, Germany
- +16 more
Jan 6, 2022
Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of
Not yet recruiting
- Meningococcal Meningitis
- batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
- +3 more
-
Surabaya, IndonesiaHusada Utama Hospital
Nov 13, 2023
Acute Deep Venous Thrombosis of Ileofemoral Vein Trial in United States (Thrombectomy)
Recruiting
- Acute Deep Venous Thrombosis of Ileofemoral Vein
- Thrombectomy
-
Darien, Connecticut
- +4 more
Jul 5, 2023
Epidemic Meningitis Trial (MCV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- (no location specified)
Jul 5, 2023
Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)
Completed
- Rheumatoid Arthritis (RA)
- tacrolimus
- +4 more
-
Daegu, Korea, Republic of
- +9 more
Aug 26, 2021
COVID-19 (SARS-CoV-2 Infection) Trial in Genova (Sentinox--Group A, Sentinox--Group B)
Completed
- COVID-19 (SARS-CoV-2 Infection)
- Sentinox--Group A
- Sentinox--Group B
-
Genova, ItalyOspedale Policlinico San Martino IRCCS
Jul 25, 2022
Digestion, Gut Microbiota Trial in Shanghai (Commercially Available Starter Infant Formula)
Recruiting
- Digestion
- Gut Microbiota
- Commercially Available Starter Infant Formula
-
Shanghai, ChinaShanghai Public Health Clinical Center
Aug 25, 2022
Oral Surgical Procedures Trial in Araraquara (Group 1: Autogenous bone graft, Group 2: Plenum® Osshp, Group 3: Plenum® Osshp; +
Recruiting
- Oral Surgical Procedures
- Group 1: Autogenous bone graft
- +3 more
-
Araraquara, Sao Paulo, BrazilUniversidade Estadual Paulista - UNESP
Nov 14, 2023
Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with
Recruiting
- Radiotracer
- +2 more
- Dexamethasone (Group 2)
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Dec 9, 2022
Toxic Optic Neuropathy, Treatment, Methylprednisolone Trial in Ciudad de mexico (Recombinant human erythropoietin 4,000 UI and
Recruiting
- Toxic Optic Neuropathy
- +3 more
- Recombinant human erythropoietin 4,000 UI and 2,000 UI
- Methylprednisolone succinate 500 mg
-
Ciudad de mexico, MexicoJorge Cárdenas Belaunzarán
Feb 20, 2023
Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous
Completed
- Common Cold
- +2 more
-
Berlin, GermanySchlesinger Group
Jan 31, 2023
Lanadelumab in Persons With Hereditary Angioedema Type I or II
Active, not recruiting
- Hereditary Angioedema (HAE)
-
Birmingham, Alabama
- +28 more
Dec 17, 2021
Looking at How Oral Semaglutide Works in People With Type 2
Completed
- Diabetes Mellitus, Type 2
- Oral Semaglutide
-
Mississauga, Ontario, CanadaNovo Nordisk Investigational Site
Nov 11, 2022
Uncontrolled Gout, Chronic Gout Trial in United States (Pegloticase and Methotrexate (MTX))
Recruiting
- Uncontrolled Gout
- Chronic Gout
- Pegloticase and Methotrexate (MTX)
-
Anchorage, Alaska
- +11 more
Dec 9, 2022
Atopic Dermatitis Trial in Canada, United States (OpSCF, Placebo, OpSCF (Open Label Extension))
Not yet recruiting
- Atopic Dermatitis
- OpSCF
- +2 more
-
Birmingham, Alabama
- +15 more
Oct 25, 2023
Correction of Nasolabial Folds Trial in Stockholm (Decoria intense)
Not yet recruiting
- Correction of Nasolabial Folds
- Decoria intense
-
Stockholm, SwedenFlorakliniken
Feb 10, 2022
Trauma Trial (4 factor Prothrombin Complex Concentrates)
Not yet recruiting
- Trauma
- 4 factor Prothrombin Complex Concentrates
- (no location specified)
Feb 21, 2023